Professional Documents
Culture Documents
BLOOMBERG INTELLIGENCE
HEALTH CARE
INDUSTRY
ANALYSIS
CONTENTS
02 KEY BENEFITS
02 INDUSTRY DEPTH
03 TOP LINE DATA
04 THIRD PARTY DATA
05 FUNDAMENTAL DATA
06 INDUSTRY ANALYSIS
07 DISEASE ANALYSIS
08 EARNINGS ANALYSIS
09 MONITOR
HEALTH CARE
INDUSTRY
ANALYSIS
Bloomberg Intelligence BI <GO> continues to evolve into a One-Stop-Shop for the health care sector.
Combined with the Bloomberg Professional service as the leader of real-time and historical news,
information and analytics, our product offering gives you unsurpassed depth and breadth at the sector,
industry and company levels. Monitor, analyze and drill down into real-time datasets quickly and effectively
on one platform.
KEY BENEFITS OF USING BLOOMBERG INTELLIGENCE BI <GO> FOR THE HEALTH CARE SECTOR:
No additional cost to existing Bloomberg Professional
Objective and succinct views on an industry from
service subscribers
experienced independent sector experts
Key 3rd party data prescription data from Symphony
E xport functionality download datasets into Microsoft
Health Solutions (formerly Wolters Kluwer), device utilization Excel, collate research reports into PDF files
data from Millennium Research Group, American Hospital
Bloomberg Intelligence is a team of 100 investment analysts
Association, CMS and AM Best
(40 seniors) covering 110+ industries
Weekly and monthly Catalyst Calendars tracking more than
4,000 events impacting the sector
INDUSTRY DEPTH
The combination of Bloombergs powerful functionality, multi-asset coverage, news, research and law products improves and
speeds the due diligence process and gives you the ability to identify client opportunities faster. By compiling extensive data across
specific industries into one platform, BI <GO> provides a comprehensive view of an industry and its key constituents.
/////////////////////////////////////////
BLOOMBERG INTELLIGENCE // 02
TOP LINE
DATA
Track global drug sales by therapy, class and
mechanism of action
See hospital and licensed beds distribution by state
Use Bloomberg Intelligence functionality to calculate
CMS reimbursement to hospitals and for the top 50
medical procedures. Follow growth rates, market
drivers and market penetration rates for medical
device categories.
BLOOMBERG INTELLIGENCE // 03
THIRD PARTY
DATA
On any therapeutics dashboard, access U.S.
prescription data for any launched drug (Symphony
Health) or build a competitive landscape of products
in development for a particular disease or mechanism
of action (Springer)
BLOOMBERG INTELLIGENCE // 04
FUNDAMENTAL
DATA
For biotech and pharmaceutical companies, we
provide all relevant profitability, balance sheet,
operating and cash data
BLOOMBERG INTELLIGENCE // 05
INDUSTRY
ANALYSIS
Research is live and interactivecontent can be saved as a PDF or sent directly to other Bloomberg
Professional service subscribers.
View thematic research on hot topics such as
clinical developments, competitive strategies
and reimbursement
Analyze R&D productivity and pipeline
developments by company
Industry Valuations
BLOOMBERG INTELLIGENCE // 06
DISEASE
ANALYSIS
Bloomberg Intelligence disease dashboards take pharmaceutical analysis to the next level. In addition to
thematic research, disease dashboards include:
Disease prevalence data
Epidemiology models that enable users to make patient
and drug forecasts
Focus on relevant products sales data and
market share
BLOOMBERG INTELLIGENCE // 07
EARNINGS
ANALYSIS
Access quarterly earnings previews that highlight
key themes expected to drive the industry
Earnings Preview
BLOOMBERG INTELLIGENCE // 08
MONITOR
Access all industry news in one location with the
ability to break out all BI research, broker research
and FirstWord market-moving news
News by Sector
Events by Sector
Comp Sheets
BLOOMBERG INTELLIGENCE // 09
ABOUT THE
BLOOMBERG
PROFESSIONAL
SERVICE
Bloomberg, the global business and financial information and
news leader, gives influential decision makers a critical edge
by connecting them to a dynamic network of information,
people and ideas. The companys strengthdelivering data,
news and analytics through innovative technology, quickly
and accuratelyis at the core of the Bloomberg Professional
service, which provides real time financial information to more
than 315,000 subscribers globally.
Asthika Goonewardene
Large Pharmaceuticals
Generic Pharmaceuticals
Multiple Sclerosis
Biotech
Diabetes
agoonewarden@bloomberg.net
Elizabeth Krutoholow
Biotech
Specialty Pharmaceuticals
ekrutoholow@bloomberg.net
Asthika Goonewardene
Health care Analyst
+44 20 7330 7273
agoonewarden@bloomberg.net
DUBAI
+971 4 364 1000
HONG KONG
+852 2977 6000
MILAN
+39 02 8064 4225
NEW YORK
+1 212 318 2000
SO PAULO
+55 11 2395 9000
SYDNEY
+61 2 9777 8600
FRANKFURT
+49 69 9204 1210
LONDON
+44 20 7330 7500
MUMBAI
+91 22 6120 3600
SAN FRANCISCO
+1 415 912 2960
SINGAPORE
+65 6212 1000
TOKYO
+81 3 3201 8900
bloomberg.com
The BLOOMBERG PROFESSIONAL service, BLOOMBERG Data and Bloomberg Intelligences (the Services) are owned and distributed by Bloomberg Finance L.P. (BFLP) in all jurisdictions other than Argentina, Bermuda, China, India,
Japan and Korea (the BLP Countries). BFLP is a wholly owned subsidiary of Bloomberg L.P. (BLP). BLP provides BFLP with global marketing and operational support and service for the Services and distributes the Services either directly
or through a non-BFLP subsidiary in the BLP Countries. Certain functionalities distributed via the Services are available only to sophisticated institutional investors and only where the necessary legal clearance has been obtained. BFLP, BLP
and their affiliates do not guarantee the accuracy of prices or information in the Services. Nothing in the Services shall constitute or be construed as an offering of financial instruments by BFLP, BLP or their affiliates, or as investment advice or
recommendations by BFLP, BLP or their affiliates of an investment strategy or whether or not to buy, sell or hold an investment. Information available via the Services should not be considered as information sufficient upon which to base
an investment decision. BLOOMBERG, BLOOMBERG PROFESSIONAL, BLOOMBERG MARKETS, BLOOMBERG NEWS, BLOOMBERG ANYWHERE, BLOOMBERG TRADEBOOK, BLOOMBERG TELEVISION, BLOOMBERG RADIO,
BLOOMBERG PRESS and BLOOMBERG.COM are trademarks and service marks of BFLP, a Delaware limited partnership, or its subsidiaries. 2014 Bloomberg Finance L.P. All rights reserved. S45029900 0714